Positive effects are seen on the spirometer market. The major market participants are actively assisting the healthcare systems and professionals as the spread of the coronavirus (COVID-19) continues across the international community. Growth in several economies across numerous industries has been hampered by this epidemic. One of the top causes of mortality worldwide is respiratory illness. Additionally, the third most common cause of mortality is chronic obstructive pulmonary disease (COPD). The COVID-19 epidemic has increased the prevalence of respiratory illnesses. As a result, it is projected that the number of ARDS patients who need respiratory assistance would rise, which might lead to a rise in the need for spirometers.
Allergies, climate change, and air pollution are further propelling the Spirometer Market expansion. The expansion of the market is being driven by the creation of technologically sophisticated devices, governmental approvals, and product launches. However, lack of knowledge about respiratory illnesses and the existence of spirometer alternatives limit market expansion. Additionally, authorities and governments are projected to take more actions to enhance healthcare systems and raise awareness of the advantages of spirometers, which will help the worldwide spirometer market develop.
